BRIEF published on 09/23/2024 at 08:20, 7 months 22 days ago Tissue Regenix Group Achieves First Pre-Tax Profit Market Expansion Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 09/23/2024 at 08:20, 7 months 22 days ago Tissue Regenix Group réalise son premier bénéfice avant impôts Bénéfice Avant Impôts Expansion Du Marché Tissu Regenix Réparation Des Tissus Mous Réparation Osseuse
PRESS RELEASE published on 09/23/2024 at 08:15, 7 months 22 days ago Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit Hardman & Co Research reports on Tissue Regenix (TRX) achieving maiden pre-tax profit. TRX focuses on soft tissue and bone repair technologies, showing strong growth and profitability Hardman & Co Research Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 06/25/2024 at 10:48, 10 months 20 days ago Decline of UK Life Sciences Sector Raises Concerns Investment Tissue Regenix Institutional Support UK Life Sciences Healthcare Index
BRIEF published on 06/25/2024 at 10:48, 10 months 20 days ago Le déclin du secteur britannique des sciences de la vie suscite des inquiétudes Investissement Régénix Des Tissus Sciences De La Vie Au Royaume-Uni Indice De Santé Appui Institutionnel
PRESS RELEASE published on 06/25/2024 at 10:43, 10 months 20 days ago Hardman & Co Insight: Survival of the UK life sciences sector Hardman & Co Research presents insights on the survival of the UK life sciences sector, highlighting challenges and opportunities for institutional investors. Discover more in the full report Investment Opportunities Hardman & Co Research Institutional Investors UK Life Sciences Sector Healthcare Stocks
BRIEF published on 04/10/2024 at 08:20, 1 year 1 month ago Hardman & Co Research Highlights Tissue Regenix's Impressive Growth Streak EBITDA Growth Tissue Regenix DCELL® BioRinse®
BRIEF published on 04/10/2024 at 08:20, 1 year 1 month ago Hardman & Co Research met en évidence la séquence de croissance impressionnante de Tissue Regenix Croissance BAIIA DCELL® BioRinse® Régénix Des Tissus
PRESS RELEASE published on 04/10/2024 at 08:15, 1 year 1 month ago Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth Hardman & Co Research highlights Tissue Regenix (TRX) with six consecutive periods of >20% growth, backed by strong commercial partners and expansion plans Hardman & Co Research Growth Investments Tissue Regenix EBITDA-positive
PRESS RELEASE published on 09/18/2023 at 11:40, 1 year 7 months ago Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
Published on 05/15/2025 at 20:00, 35 minutes ago Critical Elements Announces the Results from the Annual Meeting of Shareholders
Published on 05/15/2025 at 20:00, 35 minutes ago Critical Elements annonce les résultats de l'assemblée annuelle des actionnaires
Published on 05/15/2025 at 19:00, 1 hour 35 minutes ago D. Boral Capital Acted as Exclusive Placement Agent to ADS-TEC Energy (Nasdaq: ADSE) in connection with its up to $50.0 Million Registered Direct Offering
Published on 05/15/2025 at 17:55, 2 hours 40 minutes ago Spetz Retracts and Clarifies its News Release From May 14th
Published on 05/15/2025 at 16:30, 4 hours 5 minutes ago Namibia Critical Metals Announces Results of Annual General Meeting of Shareholders
Published on 05/15/2025 at 19:03, 1 hour 32 minutes ago Funding Circle Holdings plc: RAG-Result of AGM
Published on 05/15/2025 at 18:36, 1 hour 59 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/15/2025 at 18:29, 2 hours 6 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/15/2025 at 18:11, 2 hours 24 minutes ago bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
Published on 05/15/2025 at 18:10, 2 hours 25 minutes ago Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Published on 05/15/2025 at 20:00, 35 minutes ago ALTAREIT : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 5 juin 2025
Published on 05/15/2025 at 20:00, 35 minutes ago ALTAREA : Dates clefs du dividende 2024 (proposé à l'assemblée générale du 5 juin 2025)
Published on 05/15/2025 at 20:00, 35 minutes ago ALTAREA : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 5 juin 2025
Published on 05/15/2025 at 19:19, 1 hour 16 minutes ago ENTECH franchit les 90 M€ d’entrées en commandes depuis le début de l’exercice 2025 en signant un contrat portant sur la construction de 2 centrales photovoltaïques au sol
